DOI QR코드

DOI QR Code

Subcutaneous Four-Week Repeated Dose Toxicity Studies of Rice Cell-Derived Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Rats

  • Published : 2008.12.01

Abstract

Recombinant human granulocyte-macrophage colony stimulating factor (hGM-CSF) is a glycoprotein and hematopoietic growth factors that regulates the proliferation of myeloid precursor cells and activates mature granulocytes and macrophages. In a previous study, we reported that hGM-CSF could be produced in transgenic rice cell suspension culture, termed rhGM-CSF. In the present study, we examined the repeated dose toxicity of rhGM-CSF in SD rats. The repeated dose toxicity study was performed at each dose of 50 and 200 ${\mu}g/kg$ subcutaneous administration of rhGM-CSF everyday for 28-days period. The results did not show any changes in food and water intake. There were also no significant changes in both body and organ weights between the control and the tested groups. The hematological and blood biochemical parameters were statistically not different in all groups. These results suggest that rhGM-CSF may show no repeated dose toxicity in SD rats under the conditions.

Keywords

References

  1. Armitage, J.O. (1998). Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. Blood, 92, 4491-4508
  2. Cantrell, M.A., Anderson, D., Cerretti, D.P., Price, V., Mckereghan, K., Tushinski, R.J., Mochizuki, D.Y., Larsen, A., Grabstein, K., Gillis, S. and Cosman, D. (1985). Cloning, sequencing, and expression of a human granulocyte/macropharge colony-stimulating factor. Proc. Natl. Acad. Sci. USA, 82, 6250-6254 https://doi.org/10.1073/pnas.82.18.6250
  3. Cho, S.A., Park, J.H., Seok, S.H., Juhn, J.H., Kim, S.J., Ji, H.J., Choo, Y.S. and Park, J.H. (2006). Effect of granulocyte macrophage-colony stimulating factor (GM-CSF) on 5- FU-induced ulcerative mucositis in hamster buccal pouches. Exper. Toxicol. Pathol., 57, 321-328 https://doi.org/10.1016/j.etp.2005.09.006
  4. Doran, P. (2000). Foreign protein production in plant tissue cultures. Trends Biotechnol., 11, 199-204
  5. Dorr, R.T. (1993). Clinical properties of yeast-derived versus Escherichia coli-derived granulocyte-macrophage colony stimulating factor. Clin. Ther., 15, 19-29
  6. Giddings, G. (2001). Transgenic plants as protein factories. Curr. Opin. Biotechnol., 12, 450-454 https://doi.org/10.1016/S0958-1669(00)00244-5
  7. Han, J.H., Hesson Chung, Lee, J.H., Suh, J.E., Lee, G.S., Kim, J.C. and Kang, B.H. (2004). Single and two-week repeated oral dose toxicity study of DHP2, a hydrophobic drug delivery vehicle in mice. J. Toxicol. Pub. Health, 20, 123-129
  8. Hovgaard, D., Mortensen, B.T., Schifter, S. and Nissen, N.I. (1993). Comparative pharmacokinetics of single-dose administration of mammalian and bacterially-derived recombinant human granulocyte-macrophage colony-stimulating factor. Eur. J. Haematol., 50, 32-36
  9. Ji, J.E., Lee, J.M., Choi, J.M., Choi, Y.H., Kim, S.K., Ahn, K.H., Lee, D.H., Kim, H.H., Han, K.B. and Kim, D.K. (2007). Intravenous single and two week repeated dose toxicity studies of rice cells-derived recombinant human granulocyte-macrophage colony-stimulating factor on rats. J. Toxicol. Pub. Health, 23, 383-389 https://doi.org/10.5487/TR.2007.23.4.383
  10. Kim, H.J., Lee, D.H., Kim, D.K., Han G.B. and Kim, H.J. (2008). The glycosylation and in vivo stability of human granulocyte-macrophage colony-stimulating factor produced in rice cells. Biol. Pharm. Bull., 31, 290-294 https://doi.org/10.1248/bpb.31.290
  11. Kim, Y.C., Kim, H.J., Kong, M.K., Lim, A.K., Kwon, M.H., Kim, K.S. and Lee, G.D. (2007). Single and four-week repeated oral toxicity study of antidiabetic herb extract microcapsule in sprague-dawley rats. J. Toxicol. Pub. Health, 23, 87-96 https://doi.org/10.5487/TR.2007.23.1.087
  12. Krumwieh, D., Weinmann, E., Siebold, B. and Seiler, FR. (1990). Preclinical studies on synergistic effects of IL-1, IL-3, G-CSF and GM-CSF in cynomolgus monkeys. Int. J. Cell Cloning, 8, 229-248 https://doi.org/10.1002/stem.5530080722
  13. Lee, F., Yokota, T., Otsuka, T., Gemmell, L., Larson, N., Luh, J., Aria, K. and Rennick, D. (1985). Isolation of cDNA for a human granulocyte-macropharge colony-stimulating factor by functional expression in mammalian cells. Proc.Natl. Acad. Sci. USA, 82, 4360-4364 https://doi.org/10.1073/pnas.82.13.4360
  14. Lieschke, G.J. and Burgess, A.W. (1992). Granulocyte colonystimulating factor and granulocyte-macrophage colonystimulating factor. N. Engl. J. Med., 327, 99-106 https://doi.org/10.1056/NEJM199207093270207
  15. Lowry, N.J., Rosebrough, A.L., Farr, R.J. and Randall. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275
  16. Metcalf, D. (1991). Control of granulocytes and macropharges: molecular, cellular, and clinical aspects. Science, 254, 529- 533 https://doi.org/10.1126/science.1948028
  17. Okamoto, M., Nakai, M., Nakayama, C., Yanagi, H., Matsui, H., Noguchi, H., Namiki, M., Sakai, J., Kadota, K. and Fukui, M. (1991). Purification and characterization of three forms of differently glycosylated recombinant human granulocyte- macrophage colony-stimulating factor. Arch. Biochem. Biophys., 286, 562-568 https://doi.org/10.1016/0003-9861(91)90080-3
  18. Ragnhammar, P., Friesen, H.J., Frodin, J.E., Lefvert, A.K., Hassan, M., Osterborg, A. and Mellstedt, H. (1994). Induction of anti-recombinant human granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) antibodies and clinical effects in nonimmunocompromised patients. Blood, 84, 4078-4087
  19. Rasko, J.E. and Gough, N.M. (1994). Granulocyte-macrophage colony stimulating factor: The cytokine handbook (Thomson, Ed.). Academic Press, London, pp. 343-369
  20. Sardana, R., Dudani, A.K., Tackaberry, E., Alli, Z., Porter, S., Rowlandson, K., Ganz, P. and Altosaar, I. (2007). Biologically active human GM-CSF produced in seeds of transgenic rice plants. Transgenic Res., 16, 713-721 https://doi.org/10.1007/s11248-006-9062-y
  21. Shin, Y.J., Hong, S.Y., Kwon, T.H., Jang, Y.S. and Yang, M.S. (2003). High level of expression of recombinant human granulocyte-macrophage colony stimulating factor in transgenic rice cell suspension culture. Biotechnol. Bioeng., 82, 778-783 https://doi.org/10.1002/bit.10635
  22. Song, S.W., Jung, W. and Hong, D.H. (2006). Thirteen-week repeated-dose toxicity studies of STB-HO-BM in rats. J. Toxicol. Pub. Health, 22, 135-144
  23. Song, Z.P., Lu, B.R., Zhu, Y.G. and Chen, J.K. (2003). Gene flow from cultivated rice to the wild species Oryza rufipogon under experimental field conditions. New Phytol., 157, 657-665 https://doi.org/10.1046/j.1469-8137.2003.00699.x
  24. Vandekerckhove, J., Damme, J., van Lijsebettens, M., Botterman, J., De Block, M., Vandewiele, M., De Clercq, A., Leemans, J., van Montagu, M. and Krebbers, E. (1989). Enkephalins produced in transgenic plants using modified 2S seed storage proteins. Biotechnology (N.Y.), 7, 929-932 https://doi.org/10.1038/nbt0989-929
  25. Vazquez, J.A., Gupta, S. and Villanueva, A. (1998). Potential utility of recombinant human GM-CSF as adjunctive treatment of refractory oropharyngeal candidiasis in AIDS patients. Eur. J. Clin. Microbiol. Infect. Dis., 17, 781-783 https://doi.org/10.1007/s100960050185
  26. Wadhwa, M., Skog, A.-L., Bird, C., Ragnhammar, P., Liljefors, M., Gaines-Das, R., Mellstedt, H. and Thorpe, R. (1999). Immunogenicity of granulocyte-macrophage colonystimulating factor (GM-CSF) products in patients undergoing combination therapy with GM-CSF. Clin. Cancer Res., 5, 1353-1361
  27. Wong, G.G., Witek, J.S., Temple, P.A., Wikens, K.M., Leary, A.C., Luxenberg, D.P., Jones, S.S., Brown, E.L., Kay, R.M., Orr, E.C., Shoemaker, C., Golde, D.W., Kaufman, R.J., Hewick, R.M., Wang, E.A. and Clark, S.C. (1985). Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science, 228, 810-815 https://doi.org/10.1126/science.3923623